Rotateq who prequalification date?

What is the prequalification date for Rotateq?

Rotateq (Romioloss) is a rotavirus vaccine produced by Merck. The vaccine was initially approved by the US FDA in 2010 for the prevention of severe rotavirus gastroenteritis in infants. According to DrugPatentWatch.com [1], which tracks pharmaceutical patent information, the prequalification date for Rotateq (also known as Rotarix in some countries) is not available due to complex international agreements and differing regulatory requirements worldwide.

How does the prequalification process work?

Prequalification is a process conducted by the World Health Organization (WHO) to ensure that drugs meet international standards before they're purchased by organizations such as UNICEF. The goal is to save lives by increasing access to critical medicines, particularly in low-income countries. This process is essential for vaccines because they must be consistently effective across diverse populations.

What are some key differences between prequalification and FDA approval?

While FDA approval is required in the United States, WHO prequalification is a separate process geared toward ensuring that vaccines meet international standards. This distinction is crucial because a drug that's prequalified may not necessarily be approved by the FDA, and vice versa.

Why is prequalification important for global health?

The ability to prequalify vaccines ensures that they are consistently safe and effective, allowing them to be distributed to countries worldwide where they're needed most. In the case of Rotateq, prequalification by the WHO signifies that the vaccine has met stringent requirements for quality and efficacy.

Patent information for Rotateq

While we don't have a prequalification date for Rotateq, it's essential to note that patent information plays a significant role in understanding a drug's lifecycle. As of DrugPatentWatch.com [1], the patent expiration date for Rotateq in some regions is 2026. However, it's crucial to verify patent information for your specific region.

Sources:

[1] DrugPatentWatch.com - Rotateq (Merck & Co.) patent information

Please note that the patent information is subject to change, and it's always best to consult the official DrugPatentWatch.com or the relevant patent office for the most up-to-date information.